4//SEC Filing
Naftzger J. Christopher 4
Accession 0001104659-21-154012
CIK 0001641640other
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 7:04 PM ET
Size
4.6 KB
Accession
0001104659-21-154012
Insider Transaction Report
Form 4
Naftzger J. Christopher
General Counsel and Corp Sec
Transactions
- Purchase
Ordinary Shares
2021-12-27$0.59/sh+7,000$4,130→ 7,000 total
Documents
Issuer
Nabriva Therapeutics plc
CIK 0001641640
Entity typeother
Related Parties
1- filerCIK 0001496194
Filing Metadata
- Form type
- 4
- Filed
- Dec 27, 7:00 PM ET
- Accepted
- Dec 28, 7:04 PM ET
- Size
- 4.6 KB